AJP - Endo Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 276: E1171-E1193, 1999;
0193-1849/99 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Caumo, A.
Right arrow Articles by Cobelli, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caumo, A.
Right arrow Articles by Cobelli, C.
Vol. 276, Issue 6, E1171-E1193, June 1999

MODELING IN PHYSIOLOGY
Undermodeling affects minimal model indexes: insights from a two-compartment model

Andrea Caumo1, Paolo Vicini2, Jeffrey J. Zachwieja3, Angelo Avogaro4, Kevin Yarasheski5, Dennis M. Bier6, and Claudio Cobelli7

1 San Raffaele Scientific Institute, 20100 Milan; 4 Department of Metabolic Diseases and 7 Department of Electronics and Informatics, University of Padova, 35131 Padua, Italy; 2 Department of Bioengineering, University of Washington, Seattle, Washington 98195; 3 Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, Louisiana 70808; 5 Metabolism Division, Washington University School of Medicine, Saint Louis, Missouri 63110; and 6 Children's Nutrition Research Center, Baylor College of Medicine, Houston, Texas 77030-2600


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
THE COLD AND HOT...
A TWO-COMPARTMENT MODEL OF...
COLD GLUCOSE EFFECTIVENESS
COLD INSULIN SENSITIVITY
HOT GLUCOSE EFFECTIVENESS
HOT INSULIN SENSITIVITY
CONCLUSIONS
REFERENCES
APPENDIX A
APPENDIX B
APPENDIX C
APPENDIX D
APPENDIX E
APPENDIX F

The classic (hereafter cold) and the labeled (hereafter hot) minimal models are powerful tools to investigate glucose metabolism. The cold model provides, from intravenous glucose tolerance test (IVGTT) data, indexes of glucose effectiveness (SG) and insulin sensitivity (SI) that measure the effect of glucose and insulin, respectively, to enhance glucose disappearance and inhibit endogenous glucose production. The hot model provides, from hot IVGTT data, indexes of glucose effectiveness (S*<SUB>G</SUB>) and insulin sensitivity (S*<SUB>I</SUB>) that, respectively, measure the effects of glucose and insulin on glucose disappearance only. Recent reports call for a reexamination of some of the assumptions of the minimal models. We have previously pointed out the criticality of the single-compartment description of glucose kinetics on which both the minimal models are founded. In this paper we evaluate the impact of single-compartment undermodeling on SG, SI, S*<SUB>G</SUB>, and S*<SUB>I</SUB> by using a two-compartment model to describe the glucose system. The relationships of the minimal model indexes to the analogous indexes measured with the glucose clamp technique are also examined. Theoretical analysis and simulation studies indicate that cold indexes are more affected than hot indexes by undermodeling. In particular, care must be exercised in the physiological interpretation of SG, because this index is a local descriptor of events taking place in the initial portion of the IVGTT. As a consequence, SG not only reflects glucose effect on glucose uptake and production but also the rapid exchange of glucose between the accessible and nonaccessible glucose pools that occurs in the early part of the test.

insulin sensitivity; glucose effectiveness; mathematical model; intravenous glucose tolerance test; glucose clamp


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
THE COLD AND HOT...
A TWO-COMPARTMENT MODEL OF...
COLD GLUCOSE EFFECTIVENESS
COLD INSULIN SENSITIVITY
HOT GLUCOSE EFFECTIVENESS
HOT INSULIN SENSITIVITY
CONCLUSIONS
REFERENCES
APPENDIX A
APPENDIX B
APPENDIX C
APPENDIX D
APPENDIX E
APPENDIX F

THE INTRAVENOUS GLUCOSE TOLERANCE TEST (IVGTT), standard or modified with a tolbutamide or insulin injection, interpreted with the classic minimal model of glucose disappearance (hereafter cold minimal model) (6-10), is a powerful research tool to investigate glucose metabolism in physiopathological and epidemiological studies; more than 350 papers have appeared until 1998. The model provides two metabolic indexes measuring glucose effectiveness (SG) and insulin sensitivity (SI). SG and SI are composite parameters, i.e., they measure the overall effect of glucose and insulin, respectively, to enhance glucose disappearance (Rd) and inhibit endogenous glucose production (EGP). To segregate the effect of glucose and insulin on Rd and EGP, a labeled (hereafter hot) IVGTT has been introduced, i.e., a glucose tracer has been added to the glucose bolus (2, 17, 19, 23). The hot IVGTT interpreted with a minimal model of labeled glucose disappearance (hereafter hot minimal model) provides new indexes of glucose effectiveness (S*<SUB>G</SUB>) and insulin sensitivity (S*<SUB>I</SUB>) that measure the effects of glucose and insulin, respectively, on glucose disposal only (19, 23).

Several investigators have recently reexamined some of the minimal model assumptions (16-18, 22-24, 27, 30, 32). We have found some unexpected relationships between the cold and hot indexes (17, 19); in addition, we have observed that when EGP is derived by combining the cold and hot minimal models, its time course is physiologically absurd (17). Quon et al. (30) have shown in a study on insulin-dependent diabetes mellitus patients that SG is likely to be overestimated. Saad et al. (32) have shown that SI obtained from an insulin-modified IVGTT is well correlated but markedly underestimated compared with the insulin sensitivity index obtained with the glucose clamp technique. Finegood and Tzur (24) have shown in dogs that decreased SG associated with decreased insulin response is an artifact of the minimal model method and that SG is poorly correlated with the glucose effectiveness index obtained with the glucose clamp technique.

We have suggested two possible areas of model error (16, 18, 22, 23, 38): the monocompartmental structure of both the minimal models and the description of EGP embodied in the cold minimal model. We have shown that the monocompartmental structure is the major area responsible for the implausible EGP profile and that a two-compartment hot minimal model provides not only a reliable profile of EGP by deconvolution (14, 39) but also tracer-based indexes of glucose effectiveness, insulin sensitivity, and plasma clearance rate (37). Recently, we have used the two-compartment paradigm (18, 22, 38) to explain the findings of Quon et al. (30) and Saad et al. (32) and the poor agreement between SG and the clamp-based index of glucose effectiveness (24).

The aim of the present paper is to use a two-compartment model of glucose metabolism to explain the mechanisms by which monocompartmental undermodeling affects both cold and hot minimal model indexes.

Glossary

A1, A2; <IT>A</IT>*<SUB>1</SUB>, <IT>A</IT>*<SUB>2</SUB> Coefficients of two-exponential cold and hot glucose decay during an IVGTT at basal insulin, mg/dl and dmp/ml (for a radiolabeled IVGTT)
D, D* Cold and and hot glucose IVGTT dose, mg/kg and dpm/kg, respectively
EGP(t) Endogenous glucose production, mg · kg-1 · min-1
EGPb Endogenous glucose production in the basal state, mg · kg-1 · min-1
g(t), g*(t) Cold and hot glucose concentration in plasma, mg/dl and dpm/ml, respectively
g(0), g*(0) Minimal model estimates of cold and hot glucose concentration at time 0+, mg/dl and dpm/ml, respectively
gb Plasma glucose concentration in basal state, mg/dl
g2(t), &gtilde;*2(t) Cold and hot glucose concentration in the second pool of the two-compartment model, mg/dl and dpm/ml, respectively
 &gtilde;2(t), &gtilde;*2(t) As above, with insulin-dependent removal moved to the accessible pool, mg/dl and dpm/ml, respectively
GE, GE* Cold and hot glucose effectiveness of the two-compartment model, ml · kg-1 · min-1
GEb Cold glucose effectiveness measured from the area under the glucose excursion during an IVGTT at basal insulin, ml · kg-1 · min-1
GINF(t) Glucose infusion rate during the glucose clamp, mg · kg-1 · min-1
k21, k12, k02, kd, Rate parameters of the two-compartment model, min-1
k22 k22 = k12+k02, min-1
ka Rate constant of the remote insulin compartment in the two-compartment model, min-1
kbd, kbp Parameters describing insulin effect on glucose uptake and EGP in the two-compartment model, min-2 · ml · µU-1, respectively
kp Parameter describing glucose effect on EGP in the two-compartment model, min-1
i(t) Insulin concentration in plasma, µU/ml
ib Plasma insulin concentration in the basal state, µU/ml
IS,IS* Cold and hot insulin sensitivity of the two-compartment model, ml · kg-1 · min-1 per µU/ml
PCRb Plasma glucose clearance in the basal state, ml · kg-1 · min-1
p1, p2; <IT>p</IT>*<SUB>1</SUB>, <IT>p</IT>*<SUB>2</SUB> Cold and hot minimal model rate parameters, min-1
qi(t), <IT>q</IT>*<SUB>i</SUB>(t) Cold and hot glucose mass in ith compartment of the two-compartment model (i = 1, 2), mg and dpm, respectively
Rd(t) Glucose disappearance rate from the accessible pool, mg · kg-1 · min-1
Rd,0 Nonzero intercept of the relationship Rd vs. g, mg · kg-1 · min-1
SG, S*<SUB>G</SUB> Minimal model estimates of cold and hot glucose effectiveness, min-1
SG(clamp),SG,d(clamp) Glucose clamp measurements of cold and hot glucose effectiveness, ml · kg-1 · min-1
SI, S*<SUB>I</SUB> Minimal model estimates of cold and hot insulin sensitivity, min-1 · µU · ml-1
SI(clamp),SI,d(clamp) Glucose clamp measurements of cold and hot insulin sensitivity, ml · kg-1 · min-1 · µU-1 · ml
t Time, min
V,V* Cold and hot minimal model volume, ml/kg
V1 Volume of the accessible pool of the two-compartment model, ml/kg
VT Total glucose distribution volume, ml/kg
x(t), x*(t) Cold and hot minimal model insulin action, min-1
X(t) Two-compartment model insulin action, i.e., X = xp+xd, min-1
&Xtilde;(t) As above, with insulin-dependent removal moved to the accessible pool, i.e., &Xtilde; = xp + x~ d, min-1
xd(t) Two-compartment model insulin action on glucose uptake, min-1
x~ d(t), <IT><A><AC>x</AC><AC>˜</AC></A></IT>*<SUB>d</SUB>(t) As above, with insulin-dependent removal moved to the accessible pool (the asterisk denotes tracer-based calculation), min-1
xp(t) Two-compartment model insulin action on EGP, min-1
 alpha (t) Deviation of hot glucose decay from a two-exponential function during an IVGTT at basal insulin, dpm/ml
 gamma  gamma  = k21k12, min-2
 lambda 1, lambda 2; &lgr;*<SUB>1</SUB>, &lgr;*<SUB>2</SUB> Fast and slow eigenvalues of the cold and hot glucose decay during an IVGTT at basal insulin, min-1


    THE COLD AND HOT MINIMAL MODELS
TOP
ABSTRACT
INTRODUCTION
THE COLD AND HOT...
A TWO-COMPARTMENT MODEL OF...
COLD GLUCOSE EFFECTIVENESS
COLD INSULIN SENSITIVITY
HOT GLUCOSE EFFECTIVENESS
HOT INSULIN SENSITIVITY
CONCLUSIONS
REFERENCES
APPENDIX A
APPENDIX B
APPENDIX C
APPENDIX D
APPENDIX E
APPENDIX F

The Cold Model

The cold minimal model (Fig. 1) interprets plasma glucose and insulin concentrations measured during an IVGTT (standard, or modified with a tolbutamide or insulin injection). The model in its uniquely identifiable parametrization (6, 8, 9, 23) is described by
<A><AC>g</AC><AC>˙</AC></A>(<IT>t</IT>) = −[<IT>p</IT><SUB>1</SUB> + <IT>x</IT>(<IT>t</IT>)]g(<IT>t</IT>) + <IT>p</IT><SUB>1</SUB>g<SUB>b</SUB>   g(0) = g<SUB>b</SUB> + <FR><NU>D</NU><DE>V</DE></FR>
<IT><A><AC>x</AC><AC>˙</AC></A></IT>(<IT>t</IT>) = −<IT>p</IT><SUB>2</SUB><IT>x</IT>(<IT>t</IT>) + <IT>p</IT><SUB>3</SUB>[i(<IT>t</IT>) − i<SUB>b</SUB>]   <IT>x</IT>(0) = 0 (1)
where g is plasma glucose concentration (gb denotes its basal end test value), i is plasma insulin concentration (ib denotes its basal end test value), D is the glucose dose in the bolus, V is the glucose distribution volume, x is insulin action [x = (k4+k6)i', where i' is insulin in the remote compartment], and the pi values are parameters related to the ki values: p1 = k1+k5, p2 = k3, p3 = k2(k4+k6).


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 1.   The cold minimal model. See glossary for definition of terms.

Parameters p1, p2, p3, and V can be estimated from glucose and insulin data by use of nonlinear least squares parameter estimation techniques (13). From them one can calculate the cold indexes of glucose effectiveness, SG, and insulin sensitivity, SI, as
S<SUB>G</SUB> = <IT>p</IT><SUB>1</SUB> = <IT>k</IT><SUB>1</SUB> + <IT>k</IT><SUB>5</SUB> (min<SUP>−1</SUP>)
S<SUB>I</SUB> = <FR><NU><IT>p</IT><SUB>3</SUB></NU><DE><IT>p</IT><SUB>2</SUB></DE></FR> = <FR><NU><IT>k</IT><SUB>2</SUB>(<IT>k</IT><SUB>4</SUB> + <IT>k</IT><SUB>6</SUB>)</NU><DE><IT>k</IT><SUB>3</SUB></DE></FR> (min<SUP>−1</SUP> · &mgr;U<SUP>−1</SUP> · ml) (2)
SG and SI measure the effects of glucose and insulin, respectively, on both Rd and EGP. In fact, because SG is a function not only of k1, but also of k5 (see Fig. 1), it measures the ability of glucose at basal insulin to stimulate Rd and to inhibit EGP. Similarly, SI is a function not only of k1, k3, k4, but also of k6, and thus measures the ability of insulin to enhance the glucose stimulation of Rd and inhibition of EGP. Parameter p2 is the rate constant of the remote insulin compartment and governs the speed of rise and decay of insulin action.

Reference values for SG and SI have been obtained from the analysis of insulin and cold glucose data of a hot IVGTT performed in 25 normal young adults. Values for SG and SI were, respectively, 0.026 ± 0.002 min-1 and 7.3 ± 1.0 × 10-4 min-1 · µU-1 · ml. The mean precision of SG and SI estimates was 49 and 18%, respectively. Volume V was estimated as 1.66 ± 0.05 dl/kg.

The Hot Model

The hot minimal model (Fig. 2) interprets plasma hot glucose and insulin concentrations measured during a hot IVGTT, that is, an IVGTT (standard, or modified with a tolbutamide or insulin injection) in which a glucose tracer (radioactive or stable isotope) is added to the glucose bolus. Because hot glucose concentration only reflects Rd, the hot model yields indexes measuring glucose and insulin effect on Rd only. The model in its uniquely identifiable parametrization (2, 17, 19, 23) is described by
<A><AC>g</AC><AC>˙</AC></A>*(<IT>t</IT>) = −[<IT>p</IT>*<SUB>1</SUB> + <IT>x</IT>*(<IT>t</IT>)]g*(<IT>t</IT>)   g*(0) = <FR><NU>D*</NU><DE>V*</DE></FR>
<IT><A><AC>x</AC><AC>˙</AC></A></IT>*(<IT>t</IT>) = −<IT>p</IT>*<SUB>2</SUB><IT>x</IT>(<IT>t</IT>) + <IT>p</IT>*<SUB>3</SUB>[i(<IT>t</IT>) − i<SUB>b</SUB>]   <IT>x</IT>*(0) = 0 (3)
where the symbols are the same as in Eq. 1, with the asterisk denoting tracer-related variables and parameters. In particular, D* is the hot glucose dose, V* is the hot glucose distribution volume, x* is hot insulin action (proportional to remote insulin i'*, x* = k4i'*), and the <IT>p</IT>*<SUB><IT>i</IT></SUB> values are parameters related to the ki values: <IT>p</IT>*<SUB>1</SUB> = k1, <IT>p</IT>*<SUB>2</SUB> k3, and <IT>p</IT>*<SUB>3</SUB> = k2k4.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 2.   The hot minimal model. See glossary for definition of terms.

Parameters <IT>p</IT>*<SUB>1</SUB>, <IT>p</IT>*<SUB>2</SUB>, <IT>p</IT>*<SUB>3</SUB>, and V* can be estimated from insulin and hot glucose data by using nonlinear least squares parameter estimation techniques (13). From them one can calculate the hot indexes of glucose effectiveness, S*<SUB>G</SUB>, and insulin sensitivity, S*<SUB>I</SUB>, as
S*<SUB>G</SUB> = <IT>p</IT>*<SUB>1</SUB> = <IT>k</IT><SUB>1</SUB> (min<SUP>−1</SUP>)
S*<SUB>I</SUB> = <FR><NU><IT>p</IT>*<SUB>3</SUB></NU><DE><IT>p</IT>*<SUB>2</SUB></DE></FR> = <FR><NU><IT>k</IT><SUB>2</SUB><IT>k</IT><SUB>4</SUB></NU><DE><IT>k</IT><SUB>3</SUB></DE></FR> (min<SUP>−1</SUP> · &mgr;U<SUP>−1</SUP> · ml) (4)
S*<SUB>G</SUB> measures the ability of glucose at basal insulin to stimulate Rd, and S*<SUB>I</SUB> measures the ability of insulin to enhance glucose stimulation of Rd. Parameter <IT>p</IT>*<SUB>2</SUB> is the rate constant of the remote insulin compartment and governs the speed of rise and decay of hot insulin action.

Values for S*<SUB>G</SUB> and S*<SUB>I</SUB> have been obtained in the same 25 normal young subjects from the analysis of insulin and hot glucose data of the hot IVGTT. Data on 15 subjects have already been reported in previous publications (2, 17). Stable isotopes ([6-2H2]glucose and [2-2H]glucose) were employed in 19 studies, whereas a radioactive isotope ([3-3H]glucose) was employed in 6 studies. Values for S*<SUB>G</SUB> and S*<SUB>I</SUB> were, respectively, 0.0082 ± 0.0003 min-1 and 9.0 ± 1.2 × 10-4 min-1 · µU-1 · ml. The mean precision of S*<SUB>G</SUB> and S*<SUB>I</SUB> estimates was 4 and 5%, respectively. Volume V* was estimated as 1.88 ± 0.06 dl/kg.

Cold vs. Hot Indexes

The results of this study confirm previously observed trends (2, 17, 19): SG is about three times higher than S*<SUB>G</SUB> (P < 0.001), and SI is lower than S*<SUB>I</SUB> (P < 0.05). Of note is that these trends are also present when the indexes are estimated from an insulin-modified hot IVGTT (unpublished results). Thanks to the larger data base, it is now possible to assess the degree of correlation between SG and S*<SUB>G</SUB> and between SI and S*<SUB>I</SUB> (Fig. 3). Whereas a strong correlation exists between SI and S*<SUB>I</SUB> (r = 0.84, P < 0.001), SG and S*<SUB>G</SUB> are uncorrelated (r = 0.17, P > 0.15).


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 3.   Correlation between cold and hot indexes of glucose effectiveness (A) and insulin sensitivity (B). See glossary for definition of terms.

Some of the above results are unexpected and suggest the presence of some model error. SG is higher than S*<SUB>G</SUB>, in keeping with the theoretical expectation, but their ratio is too high compared with that of the analogous clamp-based indexes of cold, SG(clamp), and hot, SG,d(clamp), glucose effectiveness (subscript "d" denotes disappearance). In fact, whereas SG is about three times higher than S*<SUB>G</SUB>, SG(clamp) is only 1.5 times higher than SG,d(clamp) (11). Also, the complete lack of correlation between SG and S*<SUB>G</SUB> is surprising, because SG(clamp) and SG,d(clamp) are presumably well correlated, given that SG,d(clamp) is the major determinant (~2/3) of SG(clamp) (11).

The time courses of cold and hot insulin actions (Fig. 4) also show an unexpected trend. The cold minimal model assumes that insulin actions on Rd and EGP have the same timing, but the time lag between x and x* (caused by p2 being lower than <IT>p</IT>*<SUB>2</SUB>) violates this assumption. In addition, the profile of insulin action on EGP, calculated as the difference x - x*, is physiologically implausible (17).


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 4.   Cold and hot insulin action during a standard hot intravenous glucose tolerance test (IVGTT) in a representative subject.

Finally, the finding SI < S*<SUB>I</SUB> is unexpected, because SI, which measures insulin effect on both Rd and EGP, should be higher than S*<SUB>I</SUB>, which measures insulin effect on Rd only. This incongruity is not present when insulin sensitivity is assessed with the glucose clamp technique: in Ref. 10 SI(clamp) exceeded SI,d(clamp) [denoted as SI,p(clamp) in that paper] in each subject, with SI(clamp) and SI,d(clamp) being the clamp version analogous to SI and S*<SUB>I</SUB>, respectively.

The above inconsistencies are symptoms of model error. Two possible areas of error are the description of glucose and insulin effect on EGP embodied in the cold model and the single-compartment description of glucose kinetics (17, 18, 23). In this paper we focus on the latter only.


    A TWO-COMPARTMENT MODEL OF THE GLUCOSE SYSTEM DURING THE IVGTT
TOP
ABSTRACT
INTRODUCTION
THE COLD AND HOT...
A TWO-COMPARTMENT MODEL OF...
COLD GLUCOSE EFFECTIVENESS
COLD INSULIN SENSITIVITY
HOT GLUCOSE EFFECTIVENESS
HOT INSULIN SENSITIVITY
CONCLUSIONS
REFERENCES
APPENDIX A
APPENDIX B
APPENDIX C
APPENDIX D
APPENDIX E
APPENDIX F

To investigate the mechanisms by which single-compartment undermodeling affects the minimal model indexes, we developed a physiologically based two-compartment model to describe the glucose system during the IVGTT. The model, shown in Fig. 5, is described in detail in APPENDIX A. Briefly, the model describes both glucose kinetics and EGP during the IVGTT. The description of glucose kinetics is the same as that of the two-compartment minimal model proposed in Refs. 14 and 37. It is assumed that insulin-independent glucose disposal occurs in the accessible compartment, whereas insulin-dependent glucose disposal occurs in the nonaccessible compartment. Consistent with known physiology, insulin-independent glucose uptake accounts for the inhibitory effect of hyperglycemia on glucose clearance. It consists of two components, one constant and the other proportional to glucose concentration. Insulin-dependent glucose uptake is parametrically controlled by insulin in a remote insulin compartment. The assumption is made that, in the basal state, insulin-dependent glucose disposal is three times insulin-independent glucose disposal. EGP is described using the same functional description embodied in the cold minimal model (8, 17, 19, 23), thus allowing us to focus on the bias due to single-compartment undermodeling only. In fact, EGP inhibition is assumed to be proportional to the increment of glucose concentration above basal and to the product of glucose concentration and insulin action. In addition, as in the minimal model, insulin action on EGP is assumed to have the same timing as insulin action on glucose uptake.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 5.   The two-compartment simulation model. See glossary for definitions of terms.

To ascertain the ability of this model to describe satisfactorily the glucose system during the IVGTT, we used Monte Carlo simulation (details in APPENDIX B). Briefly, the two-compartment model with mean parameters was used to generate noise-free cold and hot glucose data during a hot IVGTT. The mean insulin profile of either a standard or an insulin-modified IVGTT was used as input to the model. Noise of appropriate characteristics was added to the data, and the noisy IVGTT data sets were then interpreted with the minimal models. We reasoned that, if the two-compartment model is a realistic representation of the glucose system during the IVGTT, the minimal model parameters estimated from the simulated data should be close to those estimated from real data and should exhibit the same trends discussed above. In addition, the relationships between the minimal model estimates of glucose effectiveness and insulin sensitivity and the analogous two-compartment model indexes should be similar to those observed experimentally between the minimal model and clamp-based indexes. These hypotheses were all confirmed. Table 1 reports the mean results of the identification of the two minimal models from simulated IVGTT data. The values of SG, SI, S*<SUB>G</SUB>, and S*<SUB>I</SUB> are similar to those reported in the literature. In particular, SI is close to the value found by Saad et al. (32) in normal subjects. This similarity is noteworthy, because the insulin sensitivity of the two-compartment model has been chosen equal to the one found by Saad et al. in normal subjects with the clamp technique (see APPENDIX A). Of note is that all the experimentally observed inconsistencies between cold and hot parameters are present: SI is lower than S*<SUB>I</SUB>, SG is twice S*<SUB>G</SUB>, and hot insulin action is faster than cold because <IT>p</IT>*<SUB>2</SUB> > p2 (e.g., for the simulated standard IVGTT, <IT>p</IT>*<SUB>2</SUB> = 0.069 vs. p2 = 0.027 min-1).

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Monte Carlo simulation results: cold and hot minimal model indexes estimated from standard and insulin-modified IVGTT

How do the minimal model indexes of glucose effectiveness and insulin sensitivity compare with the "true" indexes of the two-compartment model? To answer this question we derived indexes of glucose effectiveness, insulin sensitivity, and basal plasma clearance rate for the two-compartment model (details are provided in APPENDIX C). Of note is that these indexes are expressed in the same units as those of the corresponding clamp-based indexes. To express also the minimal model indexes in the same units, SG and SI were multiplied by V, and S*<SUB>G</SUB> and S*<SUB>I</SUB> were multiplied by V*, in keeping with the analysis reported in Vicini et al. (37). The values of the two-compartment and minimal model indexes are reported in Table 2. One can see that the cold minimal model overestimates glucose effectiveness and underestimates insulin sensitivity, in keeping with the experimental results (24, 32). S*<SUB>G</SUB>V* slightly underestimates basal glucose clearance and markedly overestimates hot glucose effectiveness, in keeping with the trend observed in Ref. 37. Specifically, S*<SUB>G</SUB> is virtually identical to the basal fractional glucose clearance of the two-compartment model (e.g., S*<SUB>G</SUB> from the standard IVGTT is 0.0102 min-1, and PCR/VT = 0.0096 min-1). This is consistent with the results of the S*<SUB>G</SUB> validation study in dogs (19). S*<SUB>I</SUB>V* slightly underestimates the hot insulin sensitivity of the two-compartment model, but no studies are available in the literature comparing the hot minimal model insulin sensitivity with the analogous clamp-based index.

                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Cold and hot glucose effectiveness and insulin sensitivity and basal plasma clearance rate for 2-compartment model and minimal models during a standard and an insulin-modified IVGTT

All in all, these results support the notion that the two-compartment model is a satisfactory representation of the glucose system during the IVGTT. We can thus use this model with confidence to analyze the impact of monocompartmental undermodeling on the cold and hot minimal model indexes and elucidate their relationships with the analogous clamp-based measures of glucose effectiveness and insulin sensitivity.


    COLD GLUCOSE EFFECTIVENESS
TOP
ABSTRACT
INTRODUCTION
THE COLD AND HOT...
A TWO-COMPARTMENT MODEL OF...
COLD GLUCOSE EFFECTIVENESS
COLD INSULIN SENSITIVITY
HOT GLUCOSE EFFECTIVENESS
HOT INSULIN SENSITIVITY
CONCLUSIONS
REFERENCES
APPENDIX A
APPENDIX B
APPENDIX C
APPENDIX D
APPENDIX E
APPENDIX F

Effects of Monocompartmental Undermodeling on SG

To examine the effects of the monocompartmental approximation on SG, we build on Ref. 18 and, for the sake of clarity, we outline the reasoning followed in that paper. Usually, SG is estimated from an IVGTT in which an insulin response is present and glucose decay depends on both glucose and insulin. However, the effects of the monocompartmental approximation on SG can be more easily determined if one first analyzes what happens during an IVGTT in which insulin is maintained at the basal level. Under these conditions, insulin action is identically equal to zero (Eq. 1), and the minimal model is described by a first-order linear differential equation
<A><AC>g</AC><AC>˙</AC></A>(<IT>t</IT>) = −S<SUB>G</SUB>[g(<IT>t</IT>) − g<SUB>b</SUB>]   g(0) = g<SUB>b</SUB> + <FR><NU>D</NU><DE>V</DE></FR> (5)
Solving Eq. 5 for glucose concentration and defining Delta g(t) = g(t- gb, one has
&Dgr;g(<IT>t</IT>) = <FR><NU>D</NU><DE>V</DE></FR> <IT>e</IT><SUP>−S<SUB>G</SUB><IT>t</IT></SUP> (6)
Thus the minimal model predicts that the decay of glucose concentration during an IVGTT at basal insulin is monoexponential, with SG as rate constant. The fractional decay rate of incremental glucose concentration (kG, min-1), namely the fraction of glucose concentration above basal that declines per unit time, is constant and equal to SG
<IT>k</IT><SUB>G</SUB>(<IT>t</IT>) = −&Dgr;<A><AC>g</AC><AC>˙</AC></A>(<IT>t</IT>)/&Dgr;g(<IT>t</IT>) = S<SUB>G</SUB> (7)
The true glucose system, however, is not monocompartmental. Using the two-compartment model presented in the previous section, one can show (APPENDIX D) that glucose decay during an IVGTT at basal insulin is described by two exponentials
&Dgr;g(<IT>t</IT>) = D(<IT>A</IT><SUB>1</SUB><IT>e</IT><SUP>−&lgr;<SUB>1</SUB><IT>t</IT></SUP> + <IT>A</IT><SUB>2</SUB><IT>e</IT><SUP>−&lgr;<SUB>2</SUB><IT>t</IT></SUP>) (8)
where lambda 1 and lambda 2 (min-1) are the fast and slow components of glucose decay, respectively (lambda 1 > lambda 2). Because of the presence of two time constants, the fractional decay rate of incremental glucose concentration is no longer constant, but time varying
<IT>k</IT><SUB>G</SUB>(<IT>t</IT>) = −&Dgr;<A><AC>g</AC><AC>˙</AC></A>(<IT>t</IT>)/&Dgr;g(<IT>t</IT>) = <FR><NU><IT>A</IT><SUB>1</SUB>&lgr;<SUB>1</SUB><IT>e</IT><SUP>−&lgr;<SUB>1</SUB><IT>t</IT></SUP> + <IT>A</IT><SUB>2</SUB>&lgr;<SUB>2</SUB><IT>e</IT><SUP>−&lgr;<SUB>2</SUB><IT>t</IT></SUP></NU><DE><IT>A</IT><SUB>1</SUB><IT>e</IT><SUP>−&lgr;<SUB>1</SUB><IT>t</IT></SUP> + <IT>A</IT><SUB>2</SUB><IT>e</IT><SUP>−&lgr;<SUB>2</SUB><IT>t</IT></SUP></DE></FR> (9)
In particular, kG(t) is higher at the beginning of the IVGTT, when the fast component of glucose decay (lambda 1) plays an important role, and lower at the end of the IVGTT, when only the slow component (lambda 2) remains in play.

We compared the glucose decay curves and the fractional decay rates of incremental glucose concentration predicted by the two-compartment and the minimal models, using for the two-compartment model the parameters of Table A1, and for the minimal model the SG and V values reported in Table 2. Figure 6 shows the glucose decay curves (A) and the fractional decay rates of incremental glucose concentration (B) predicted by the two models. The monoexponential decay curve predicted by the minimal model and the two-exponential profile generated by the two-compartment model are almost superimposable in the period of minutes 10-20 of the IVGTT but diverge thereafter, thus reproducing closely the experimental observations by Quon et al. (30). Of note is that the value of SG (0.021 min-1) lies between the values that kG takes on between 10 and 20 min [e.g., kG (minute 15) = 0.023 min-1]. These results suggest that the validity of SG as descriptor of the effect of glucose per se is confined to the initial portion of the IVGTT. The local validity of SG is probably related to the fact that, during an IVGTT with a normal insulin response, SG estimation critically depends on the glucose data collected in the early portion of the IVGTT, when glucose concentration is high over the baseline and insulin action, albeit increasing, is still low (20). Because in that part of the test both components of glucose decay are active, SG not only reflects glucose effects on Rd and EGP but also the rapid exchange of glucose between the accessible and the nonaccessible compartments occurring in the early part of the test.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 6.   Comparison between the two-compartment and the cold minimal model predictions of glucose concentration (A) and fractional decay rate of incremental glucose concentration (kG, B) during an IVGTT at basal insulin. The value of SG estimated during an IVGTT with a normal insulin response is close to the value of kG in the initial portion of the test, approximately between 10 and 20 min.

Validation of SG

Validation of SG entails its comparison with the analogous index measured with the glucose clamp method, SG(clamp). In comparing SG with SG(clamp), one is faced with the problem that such indexes have different units: SG is expressed in min-1, whereas SG(clamp) is expressed in ml · kg-1 · min-1. As previously suggested in Ref. 17, to convert them to a common unit one has to multiply SG by the minimal model volume of glucose distribution, V. The correctness of this approach has been formally demonstrated in Refs. 16 and 37. Of note is that V emerges from the minimal model method and can be individualized in each subject. In addition, multiplication of SG by V parallels the approach used in the validation studies of SI (10, 32).

The value of SGV found experimentally in the present study (4.2 ml · kg-1 · min-1) is much higher than the value of SG(clamp) in normal subjects that can be found in the literature (2.4 ml · kg-1 · min-1 in Ref. 11). The same trend is observed if the value of SGV obtained from our Monte Carlo study is compared with the glucose effectiveness index of the two-compartment model (see Table 2). The reason for SGV being almost twice SG(clamp) is that SG and SG(clamp) reflect different combinations of the fast and slow components of glucose disappearance at basal insulin, lambda 1 and lambda 2. We have shown that SG reflects the values that kG takes on between 10 and 20 min. Thus, from Eq. 9, one has
S<SUB>G</SUB>V = <FENCE><FR><NU>(<IT>A</IT><SUB>1</SUB>&lgr;<SUB>1</SUB><IT>e</IT><SUP>−&lgr;<SUB>1</SUB><IT>t</IT><SUB>0</SUB></SUP> + <IT>A</IT><SUB>2</SUB>&lgr;<SUB>2</SUB><IT>e</IT><SUP>−&lgr;<SUB>2</SUB><IT>t</IT><SUB>0</SUB></SUP>)</NU><DE>(<IT>A</IT><SUB>1</SUB><IT>e</IT><SUP>−&lgr;<SUB>1</SUB><IT>t</IT><SUB>0</SUB></SUP> + <IT>A</IT><SUB>2</SUB><IT>e</IT><SUP>−&lgr;<SUB>2</SUB><IT>t</IT><SUB>0</SUB></SUP>)</DE></FR></FENCE> V (10)
where t0 is ~15 min in subjects with a normal insulin response. Equation 10 shows that SG is influenced by both the fast and slow components of glucose disappearance. To compare quantitatively SGV with SG(clamp), it is useful to express SG as a function of lambda 2 only. By exploiting the fact that A1lambda 1e-lambda 1t0 approx  2A2lambda 2e-lambda 2t0 and A2e-lambda 2t0 approx  6A1e-lambda 1t0 (the values of A1, A2, lambda 1, and lambda 2 reported in Table D1), one has
S<SUB>G</SUB>V ≈ 2.6&lgr;<SUB>2</SUB>V (11)
SG(clamp) is measured from a hyperglycemic glucose clamp in which somatostatin is used to suppress the endogenous insulin release, and the baseline insulin is replaced by an exogenous insulin infusion (11). By applying the formal definition of glucose effectiveness reported in Eq. C1 to a hyperglycemic clamp at basal insulin, one finds that SG(clamp) is defined as the ratio of Delta (Rd - EGP) to the increment in plasma glucose concentration at steady state. Given that in the hyperglycemic steady state the increment in the exogenous glucose infusion rate, Delta GINF, equals Delta (Rd - EGP), SG(clamp) is defined as follows
S<SUB>G(clamp)</SUB> = <FR><NU>&Dgr;(R<SUB>d</SUB> − EGP)</NU><DE>&Dgr;g</DE></FR> <FENCE><SUB><IT>i</IT>=<IT>i</IT><SUB>b</SUB></SUB> = <FR><NU>&Dgr;GINF</NU><DE>&Dgr;g</DE></FR> <FENCE><SUB><IT>i</IT>=<IT>i</IT><SUB>b</SUB></SUB></FENCE></FENCE> (12)
Using the two-compartment model to describe the glucose system during the clamp, one can express SG(clamp) as a function of the parameters of the model and, specifically, of the two components of glucose disappearance at basal insulin (see derivation in APPENDIX E)
S<SUB>G(clamp)</SUB> = <FR><NU>1</NU><DE><FENCE><FR><NU><IT>A</IT><SUB>1</SUB></NU><DE>&lgr;<SUB>1</SUB></DE></FR> + <FR><NU><IT>A</IT><SUB>2</SUB></NU><DE>&lgr;<SUB>2</SUB></DE></FR></FENCE></DE></FR> (13)
It is easy to show that SG(clamp) is primarily determined by the slow component of glucose disappearance. In fact, A2/lambda 2 approx  18A1/lambda 1, and thus SG(clamp) approx  lambda 2/A2. Moreover, because 1/A2 approximates the total glucose distribution volume VT (28), and VT approx  1.3 V (see Tables 1 and A1), we can write
S<SUB>G(clamp)</SUB> ≈ &lgr;<SUB>2</SUB>V<SUB><IT>T</IT></SUB> ≈ 1.3&lgr;<SUB>2</SUB>V (14)
By comparing Eqs. 11 and 14, one realizes why SGV is about twice SG(clamp). It is worth pointing out that SGV and SG(clamp) are not only quantitatively, but also qualitatively different; SGV also reflects, in addition to glucose effect on Rd and EGP [measured by SG(clamp)], the exchange process taking place between the two glucose compartments in the early part of the IVGTT. As a consequence, the correlation between these two indexes is unlikely to be strong, as suggested by the simulation studies reported in Refs. 22 and 38.

Finegood and Tzur have compared SG with SG(clamp) in dogs (24). To allow the comparison, the authors divided SG(clamp) by the total volume of glucose distribution, VT, taken from the literature (250 ml/kg). They found that SG was higher than the ratio of SG(clamp) to VT and that such indexes were poorly correlated. These findings seem to support the notion that SG and SG(clamp) reflect different aspects of glucose effect per se. However, as we pointed out in Ref. 16, using VT to convert SG(clamp) to the same units as SG is questionable because, as we have discussed, the minimal model yields an index of glucose effectiveness, SGV, that has the same units of SG(clamp) and hinges on a volume that, in contrast to a mean value of VT, can be individualized in each subject.

SG from an IVGTT at Basal Insulin

It is commonly believed that SG estimated from an IVGTT at basal insulin is a reliable measure of glucose effectiveness, because under such conditions glucose is the only determinant of glucose decay. However, even under these optimized conditions, the validity of SG is uncertain because the minimal model forces a monoexponential function to describe a two-exponential decay. To determine whether SG estimated from an IVGTT at basal insulin is a valid measure of glucose effectiveness, it is useful to recognize that, under such experimental conditions, a minimal model-independent index of glucose effectiveness can be calculated directly from the area under glucose decay. In fact in Ref. 4 we showed that whenever insulin concentration is maintained at the basal level and exogenous glucose forces glucose to increase and return to the baseline, glucose effectiveness at basal insulin, denoted as GEb in Ref. 4, is given by the ratio between the administered amount of glucose and the area under the curve of the glycemic excursion above baseline [AUC(Delta g)]. In the case of an IVGTT at basal insulin, with the assumption that glucose decay follows the two-exponential profile of Eq. 8, GEb is given by
GE<SUB>b</SUB> = <FR><NU>D</NU><DE>AUC[&Dgr;g(<IT>t</IT>)]</DE></FR> = <FR><NU>1</NU><DE><FENCE><FR><NU><IT>A</IT><SUB>1</SUB></NU><DE>&lgr;<SUB>1</SUB></DE></FR> + <FR><NU><IT>A</IT><SUB>2</SUB></NU><DE>&lgr;<SUB>2</SUB></DE></FR></FENCE></DE></FR> (15)
Note that the expression of GEb in Eq. 15 coincides with that of SG(clamp) in Eq. 13, in keeping with the analysis carried out in Ref. 4 that ascertained the theoretical equivalence of these two measurements of glucose effectiveness. In that study (4), insulin was maintained at the basal level and glucose excursion was similar to that observed during a meal. Under those circumstances, SGV resulted in a value similar to GEb. It is presently unknown whether this also holds for an IVGTT at basal insulin, because during such an experiment the glucose profile is less smooth than during a meal, and the minimal model is unable to account for the rapid fall of glucose immediately after the glucose bolus. Nevertheless, some observations can be made. We have seen previously that, during an IVGTT with a normal insulin response, glucose decay reflects both glucose effectiveness and insulin action, and SG is mainly estimated from the glucose data collected in the initial part of the IVGTT, when insulin action is still low. During an IVGTT at basal insulin, insulin action is null throughout the test, and glucose decay is governed by glucose effectiveness only. As a result, all of the glucose data between 10 min and the end of the test contribute to SG estimation. Because the contribution of the fast component of glucose disappearance, lambda 1, soon becomes negligible (e.g., after ~30 min in normal subjects), and most of the glucose data are beyond that point in time, SG will approach the slow component of glucose disappearance, lambda 2, and the minimal model volume will approach the reciprocal of A2. Therefore, SGV is approximated by
S<SUB>G</SUB>V ≈ <FR><NU>&lgr;<SUB>2</SUB></NU><DE><IT>A</IT><SUB>2</SUB></DE></FR> (16)
Comparison of Eq. 16 with Eqs. 10 and 11 sheds some light on the reasons why the value of SG obtained from an IVGTT at basal insulin has been found to be lower than that obtained from an insulin-modified IVGTT (24): whereas the SG estimated during an insulin-modified IVGTT reflects both the fast and slow components of glucose disappearance, the SG estimated from an IVGTT at basal insulin reflects primarily the slow component. Comparison of Eqs. 15 and 16 indicates that, during an IVGTT at basal insulin, SGV will be close to GEb if A2/lambda 2 >> A1/lambda 1. Because A2/lambda 2 approx  18A1/lambda 1, it is likely that SGV estimated from an IVGTT at basal insulin is a reliable estimate of glucose effectiveness.

SG measured from an IVGTT at basal insulin has been compared with SG(clamp) in dogs by Finegood and Tzur (24). They found similar values for SG and SG(clamp) but no correlation between them. Whereas the agreement between the mean values of the two indexes is consistent with the above analysis, the absence of correlation between them is surprising. In fact, this would mean that the minimal model is not able to accurately assess glucose effectiveness, even when the IVGTT is performed at basal insulin. As pointed out in Ref. 16, one possible explanation for this finding is the relatively narrow range of glucose effectiveness observed in the group of dogs examined in that study. Another possible explanation is related to the fact that, at the end of the IVGTT studies carried out at basal insulin, glucose concentration was below the pretest level and still declining. This outcome may be due to the difficulty of obtaining a stable baseline for glucose concentration with the combined somatostatin, glucagon, and insulin infusion protocol. Alternatively, it could be the symptom of an inaccurate description of EGP in the minimal model. In fact, the model assumes that any change in glucose concentration is accompanied by a proportional and opposite change in EGP. The time course of EGP during an IVGTT at basal insulin is thus expected to mirror that of glucose concentration. However, the finding that at the end of the IVGTT glucose concentration was below the pretest level and still declining suggests that EGP was still inhibited at that time, implying that the minimal model description is not correct. This model inadequacy may have affected the accuracy of SG and worsened its concordance with SG(clamp).


    COLD INSULIN SENSITIVITY
TOP
ABSTRACT
INTRODUCTION
THE COLD AND HOT...
A TWO-COMPARTMENT MODEL OF...
COLD GLUCOSE EFFECTIVENESS
COLD INSULIN SENSITIVITY
HOT GLUCOSE EFFECTIVENESS
HOT INSULIN SENSITIVITY
CONCLUSIONS
REFERENCES
APPENDIX A
APPENDIX B
APPENDIX C
APPENDIX D
APPENDIX E
APPENDIX F

Effects of Monocompartmental Undermodeling on SI

The monocompartmental approximation also influences the minimal model estimates of insulin action and sensitivity. As shown in Ref. 18, because the model has to compensate for SG overestimation and fit the glucose data, insulin action is underestimated approximately until glucose returns to the baseline and is overestimated thereafter. This bias also affects SI, because this parameter can be expressed as the ratio between the AUCs of insulin action and insulin concentration above basal level (18). Here we build on that paper and analyze the bias affecting the minimal model insulin action and SI by comparing them with the insulin action and sensitivity of the two-compartment model. In carrying out this comparison, one must bear in mind that the cold model insulin action, x(t), represents the sum of the insulin effects on glucose uptake and production. In the two-compartment model, xd(t) is insulin action on glucose uptake, and xp(t) is insulin action on production. Thus X(t) = xp(t)+xd(t) represents exactly what x(t) represents for the minimal model. The profiles of X(t) and x(t) during a standard IVGTT are compared in Fig. 7A. X(t) was generated using the two-compartment model parameters reported in Table A1; x(t) was generated using the mean parameters SI and p2 estimated with the Monte Carlo simulation described in APPENDIX B (SI = 2.9 × 10-4 min-1 · µU-1 · ml and p2 = 0.027 min-1). It can be seen that the minimal model markedly underestimates insulin action during the first half of the test and slightly overestimates it thereafter. It must be recognized, however, that this bias originates not only from the different model order (one vs. two pools) but also from the different location of insulin action on glucose uptake (accessible vs. nonaccessible pool). To single out the effect of monocompartmental undermodeling per se, we calculated in APPENDIX F the effect that xd(t) produces on the accessible pool of the two-compartment model. We termed this effect as x~ (t). &Xtilde;(t) = xp(t) + x~ d(t) is therefore the "accessible-pool equivalent" insulin action of the two-compartment model that produces the same effect as X on plasma glucose concentration (i.e., the accessible-pool Rd remains the same). &Xtilde;(t) is shown in Fig. 7B plotted against the insulin action of the minimal model. Qualitatively speaking, &Xtilde;(t) is a delayed and blunted version of X(t).


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 7.   A: comparison between insulin action of the two-compartment and the cold minimal models during a standard IVGTT. B: insulin action of the two-compartment model, which, if applied to the accessible pool, would produce the same effect on glucose concentration as the one taking place in the nonaccessible pool. This "accessible-pool equivalent" profile of the two-compartment insulin action is contrasted with the cold minimal model insulin action. C: difference between insulin action profiles of B is the effect of monocompartmental undermodeling on cold minimal model i